These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38061677)

  • 1. Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates.
    Chang YT; Lin CY; Chen CJ; Hwang E; Alshetaili A; Yu HP; Fang JY
    Acta Biomater; 2024 Jan; 174():331-344. PubMed ID: 38061677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice.
    Liao CC; Yu HP; Yang SC; Alalaiwe A; Dai YS; Liu FC; Fang JY
    J Nanobiotechnology; 2021 Feb; 19(1):48. PubMed ID: 33588861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
    Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-engineered lipid-polymer hybrid nanoparticles of fusidic acid: an investigative study on dermatokinetics profile and MRSA-infected burn wound model.
    Thakur K; Sharma G; Singh B; Chhibber S; Katare OP
    Drug Deliv Transl Res; 2019 Aug; 9(4):748-763. PubMed ID: 30652257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils
    Lin CY; Yu HP; Chang YT; Lin ZC; Alalaiwe A; Hwang TL; Fang JY
    Biomater Sci; 2023 Jan; 11(3):873-893. PubMed ID: 36515218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus.
    Ellington MJ; Reuter S; Harris SR; Holden MT; Cartwright EJ; Greaves D; Gerver SM; Hope R; Brown NM; Török ME; Parkhill J; Köser CU; Peacock SJ
    Int J Antimicrob Agents; 2015 May; 45(5):477-84. PubMed ID: 25769787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleic acid as the active agent and lipid matrix in cilomilast-loaded nanocarriers to assist PDE4 inhibition of activated neutrophils for mitigating psoriasis-like lesions.
    Lin CY; Hsu CY; Elzoghby AO; Alalaiwe A; Hwang TL; Fang JY
    Acta Biomater; 2019 May; 90():350-361. PubMed ID: 30951898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ceftobiprole in a murine model of bacteremia and disseminated infection.
    Cumper C; Richards C; Smart J; Litherland K; Jones M
    J Med Microbiol; 2023 Oct; 72(10):. PubMed ID: 37791651
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin.
    Guo P; Xue HY; Buttaro BA; Tran NT; Wong HL
    Int J Pharm; 2020 Nov; 589():119784. PubMed ID: 32877731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous anti-MRSA phosphatiosomes mediate enhanced affinity to pulmonary surfactants for effective treatment of infectious pneumonia.
    Hsu CY; Sung CT; Aljuffali IA; Chen CH; Hu KY; Fang JY
    Nanomedicine; 2018 Feb; 14(2):215-225. PubMed ID: 29128664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection.
    Mohammad H; Kyei-Baffour K; Abutaleb NS; Dai M; Seleem MN
    J Glob Antimicrob Resist; 2019 Dec; 19():1-7. PubMed ID: 31051286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation.
    Lin ZC; Hwang TL; Huang TH; Tahara K; Trousil J; Fang JY
    Theranostics; 2021; 11(10):4567-4584. PubMed ID: 33754014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nanocomposite Dynamic Covalent Cross-Linked Hydrogel Loaded with Fusidic Acid for Treating Antibiotic-Resistant Infected Wounds.
    Toufanian S; Mohammed J; Winterhelt E; Lofts A; Dave R; Coombes BK; Hoare T
    ACS Appl Bio Mater; 2024 Mar; 7(3):1947-1957. PubMed ID: 38394042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
    Gordon O; Dikeman DA; Ortines RV; Wang Y; Youn C; Mumtaz M; Orlando N; Zhang J; Patel AM; Gough E; Kaushik A; Nuermberger EL; Upton AM; Fotouhi N; Miller LS; Archer NK
    Microbiol Spectr; 2022 Oct; 10(5):e0245121. PubMed ID: 36106881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy.
    Peel TN; Buising KL; Dowsey MM; Aboltins CA; Daffy JR; Stanley PA; Choong PF
    Antimicrob Agents Chemother; 2013 Jan; 57(1):350-5. PubMed ID: 23114758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Trends of Methicillin-Resistant Staphylococcus aureus in Gauteng Public Hospitals from 2009 to 2018.
    Segal B; Langham A; Klevansky R; Patel N; Mokoena T; Nassiep M; Ramatlo O; Ahmad A; Duse AG
    Microbiol Spectr; 2023 Aug; 11(4):e0362322. PubMed ID: 37338400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic delivery from bone-targeted mesoporous silica nanoparticles for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Aguilera-Correa JJ; Gisbert-Garzarán M; Mediero A; Fernández-Aceñero MJ; de-Pablo-Velasco D; Lozano D; Esteban J; Vallet-Regí M
    Acta Biomater; 2022 Dec; 154():608-625. PubMed ID: 36341887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
    Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
    J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.